GSK faces cancer setback; third Sarepta gene therapy patient dies
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, remains somewhat unsettled. Other than escorting Mrs. Pharmalot to an event, we plan to catch up on our reading, promenade with